El interés en corto de Intellia Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Intellia Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Intellia Therapeutics (NASDAQ:NTLA) Bolsa, Informe de interés en corto

INTELLIA THERAPEUTICS INC

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

News

ABSI

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Descubre las recientes decisiones de Ark Invest en energía, defensa y genética, con transacciones millonarias en empresas clave.

Ark Invest adquiere y vende acciones clave en energía, defensa y tecnología genética

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

In its most recent move to tackle <a href="https://www.benzinga.com/25/03/44447338/donald-trump-administration-to-strip-legal-protections-from-over-half-a-million-migrants-as-he-argues-joe-bidens-parole-programs-overstepped-federal-law">unregulated migration</a>, the Trump administration has reclassified over 6,000 living immigrants as deceased and disabled their Social Security numbers.
This move strips them of their work eligibility and pushes them to leave the country.
What Happened: According <a href="https://time.com/7276631/social-security-immigrants-trump-work-eligibility-benefits-services-self-deport/">to</a> Time Magazine, immigrants&#8217; names were moved into a federal death-tracking database, removing access to jobs, banking, and services.
Many of those targeted had legal status under Biden-era programs, including users of the CBP One app. "It wasn't immediately clear how the <a href="https://www.benzinga.com/news/25/03/44067679/trumps-immigration-policy-could-be-the-key-to-inflation-and-market-shifts-investors-warn">6,000-plus immigrants</a> were chosen," the sources speaking to Time Magazine said.
See Also: <a href="https://www.benzinga.com/personal-finance/25/04/44753700/a-waste-of-resources-u-s-spent-40-million-to-hold-400-migrants-at-guantanamo-in-just-6-weeks">A &#8216;Waste of Resources&#8217;? U.S. Spent $40 Million To Hold 400 Migrants At Guantánamo In Just 6 Weeks</a>
Why It Matters: Critics view this tactic as a strategy to force "self-deportation." "This President continues to engage in lawless behavior," said Skye Perryman of Democracy Forward, sharing plans to sue. Meanwhile, a new IRS-ICE data-sharing agreement drew widespread backlash and led to the<a href="https://www.benzinga.com/government/25/04/44708720/irs-turmoil-deepens-after-unheard-of-treasury-interference-triggers-commissioners-departure"> IRS commissioner's resignation</a>.
Legal challenges to this new move are expected as advocacy groups raise alarms about further overreach by the administration. "We will likely sue over the Social Security numbers," Perryman added.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44706330/irs-reverses-stance-agrees-to-share-undocumented-migrant-taxpayers-information-with-ice-this-is-unprecedented">IRS Reverses Stance, Will Hand Over Undocumented Taxpayer Info To Immigration Authorities: &#8216;It&#8217;s Unprecedented</a></li>
</ul>
Image via Shutterstock

Government

Regulations

General

Over 6,000 Immigrants Declared Dead By Social Security In Effort To Revoke Benefits And Force 'Self-Deportation'

Judge Trevor Neil McFadden has given the green light to the Trump administration's plan requiring undocumented immigrants to register with the federal government.
What Happened: Judge McFadden ruled Thursday in favor of the Trump administration, allowing the enforcement of a policy that mandates undocumented immigrants aged 14 and older to provide their fingerprints or face penalties, including fines or imprisonment, <a href="https://www.axios.com/2025/04/10/immigrant-registry-fingerprints-trump-administration">Axios</a> reported.
The rule, effective from Friday, is a part of the administration&#8217;s escalated efforts to control undocumented immigration.
The Trump administration first announced this plan in February. In a lawsuit filed by the Coalition for Humane Immigrant Rights (CHIRLA), the administration defended its stance, stating that it was merely enforcing the existing federal immigration law that requires non-citizens to register with the government.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44749653/bitcoin-ethereum-xrp-dogecoin-lose-steam-trader-warns-of-new-lows-under-one-condition" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Lose Steam, Trader Warns Of &#8216;New Lows&#8217; Under One Condition &#8211; Benzinga</a>
Under the new rule, undocumented immigrants are&nbsp;required to register and create&nbsp;an account on the&nbsp;U.S. Citizenship and Immigration Services&nbsp;(USCIS) online page. This rule applies to anyone residing&nbsp;in the U.S. for 30&nbsp;days or more. Once registered and fingerprinted, the Department of Homeland Security (DHS) will issue &#8220;evidence of registration,&#8221; which immigrants aged 18 and above must carry&nbsp;with them at all times,&nbsp;as per USCIS.
Why It Matters: This ruling comes amid a series of actions taken by the Trump administration to tighten immigration control. In March, the administration revoked legal status for approximately <a href="https://www.benzinga.com/25/03/44447338/donald-trump-administration-to-strip-legal-protections-from-over-half-a-million-migrants-as-he-argues-joe-bidens-parole-programs-overstepped-federal-law">530,000 migrants</a> from Cuba, Haiti, Nicaragua, and Venezuela, reversing a key policy from the Biden era. Later that month, President Trump signed an executive order to <a href="https://www.benzinga.com/markets/25/03/44550693/trump-signs-executive-order-to-combat-crime-and-toughen-immigration-enforcement-in-washington-d-c">enhance immigration enforcement</a> in Washington, D.C. 
These measures have sparked criticism, particularly due to their high cost. For instance, the U.S. government spent approximately <a href="https://www.benzinga.com/personal-finance/25/04/44753700/a-waste-of-resources-u-s-spent-40-million-to-hold-400-migrants-at-guantanamo-in-just-6-weeks">$40 million</a> in just six weeks to detain fewer than 400 migrants at the Guantánamo Bay Naval Base in Cuba, raising concerns among lawmakers about the high cost and military impact of these operations. Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:&nbsp;<a href="https://benzinga.com/news/25/04/44738770/reddit-investor-asks-is-it-possible-that-trumps-tariffs-are-a-massive-pump-and-dump-scheme-whos-going-to-inv" target="_blank" rel="noreferrer noopener">Reddit Investor Asks, &#8216;Is It Possible That Trump&#8217;s Tariffs Are A Massive Pump And Dump Scheme? Who&#8217;s Going To Investigate Or Stop Him?&#8217;</a>

Politics

Federal Judge Clears Trump Plan Requiring Undocumented Immigrants To Register Or Face Penalties

Sen. Bernie Sanders is warning American workers to prepare for enormous changes as AI and robotics reconfigure the <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44645518/strong-jobs-report-offers-hope-but-will-it-be-enough-to-counter-tariff-turmoil">job market</a>.
Speaking at a CNN town hall with Anderson Cooper earlier this week, he advised the public to consider the threat seriously.
What Happened: Sanders referred to Elon Musk's <a href="https://www.benzinga.com/25/03/44447947/big-short-investor-danny-moses-warns-of-economic-risks-from-elon-musks-doge-induced-federal-job-cuts">dismissal of federal workers</a> under the Trump administration's Department of Government Efficiency.
"If Musk can do this to federal employees, what do you think he's going to be doing when artificial intelligence and robotics come for your job?" he asked. "The job you have today ain't going to be here in 10 or 15 years."
See Also: <a href="https://www.benzinga.com/tech/25/04/44705372/ai-is-quietly-reshaping-how-companies-screen-resumes-nearly-half-of-hiring-managers-now-use-it">AI Is Quietly Reshaping How Companies Screen Resumes — Nearly Half Of Hiring Managers Now Use It</a>
Why It Matters: Sanders accused Musk and tech elites of <a href="https://www.benzinga.com/markets/25/03/44556147/mark-cuban-warns-of-red-rural-recession-as-hundreds-of-small-town-maga-supporters-reportedly-lose-federal-jobs-their-finances-will-be-turned-upside-down">prioritizing profits above people</a>. "They don't give a damn about you," Sanders said. "If this is what they could do to federal employees, think about what they could do to people in the private sector."
"I am not a Luddite," Sanders went on to add. "But new technology, AI, robotics, has got to work for working people, not just for the billionaires and Mr. Musk."
Earlier this week, Shopify CEO Tobi Lutke issued a memo announcing that the company will only recruit new workers if they can <a href="https://benzinga.com/25/04/44678363/shopify-ceo-tobi-lutke-says-employees-must-prove-ai-cant-handle-their-tasks-before-requesting-more-headcount">prove that AI cannot be used to do the job</a>. Sanders&#8217; warning appears even more stark in light of this new development.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44673195/you-have-defeated-the-wealthiest-person-on-earth-says-bernie-sanders-as-he-applauds-wisconsins-choice-of-susan-crawford">&#8216;You Have Defeated The Wealthiest Person On Earth,&#8217; Says Bernie Sanders As He Applauds Wisconsin&#8217;s Choice Of Susan Crawford</a></li>
</ul>
Photo courtesy: Shutterstock

Bernie Sanders Warns: 'The Job You Have Today Ain't Going To Be Here In 10 Or 15 Years,' As AI And Robotics Threaten US Workforce

Management

IAUX

i-80 GOLD President & Chief Operating Officer Matthew Gili To Step Down; New COO Search Begins

Health Care

BRKR

Bruker To Partner With Ridom For NGS Bioinformatics Applications In Microbiology And Infectious Disease Testing

UNTY

Unity Bancorp Q1 Customer Deposits Increase 4.82% To $90.7M

Unity Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNTY#NASDAQ">UNTY</a>) reported quarterly earnings of $1.13 per share which met the analyst consensus estimate. This is a 21.51 percent increase over earnings of $0.93 per share from the same period last year.

Earnings

Unity Bancorp Q1 EPS $1.13, Inline

Dividends

BlackRock Announces Increase Of 2% In Quarterly Cash Dividend Per Share To $5.21 From $5.10 Year Ago

BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) reported quarterly earnings of $11.30 per share which beat the analyst consensus estimate of $11.14 by 1.44 percent. This is a 15.19 percent increase over earnings of $9.81 per share from the same period last year. The company reported quarterly sales of $5.28 billion which missed the analyst consensus estimate of $5.60 billion by 5.72 percent. This is a 11.59 percent increase over sales of $4.73 billion the same period last year.

Earnings Beats

Earnings Misses

BlackRock Q1 2025 Adj EPS $11.30 Beats $11.14 Estimate, Sales $5.28B Miss $5.60B Estimate

Mira Murati, the former chief technology officer of ChatGPT-parent OpenAI, is reportedly seeking to raise a staggering $2 billion seed round for her new AI venture, Thinking Machines Lab.
What Happened: The amount is twice the amount Murati was targeting just under two months ago, when she was said to be seeking around $1 billion at a $9 billion valuation, <a href="https://www.businessinsider.com/mira-murati-new-ai-startup-thinking-machines-funding-2025-4">reported</a> Business Insider, citing people familiar with the matter.
If confirmed, it would be one of the largest seed rounds in tech history, dwarfing previous records and reaffirming the continued investor frenzy around artificial intelligence.
See Also:&nbsp;<a href="https://www.benzinga.com/media/25/03/44566020/arm-aims-for-50-data-center-cpu-market-share-by-2025-challenging-intel-and-amd">Arm Aims for 50% Data Center CPU Market Share by 2025, Challenging Intel and AMD</a>
Consider OpenAI cofounder Ilya Sutskever, who raised <a href="https://www.benzinga.com/news/24/09/40722123/openai-co-founder-ilya-sutskevers-ai-startup-raises-1b-from-andreessen-horowitz-sequoia-as-sam-altma">$1 billion in seed funding</a> for his new venture, Safe Superintelligence — a company that has already been pegged with a massive <a href="https://www.benzinga.com/tech/25/02/43772135/ex-openai-chief-scientist-ilya-sutskevers-ai-startup-valued-at-30-billion-in-latest-funding-round-report">$30 billion valuation</a>.
Another notable example is Sierra, a conversational AI startup launched in 2023 by Bret Taylor, who also chairs OpenAI and previously co-led Salesforce. That company has reportedly <a href="https://www.benzinga.com/news/24/10/41591558/bret-taylors-ai-startup-sierra-hits-4-5b-valuation-just-a-year-after-launch-openai-chairs-latest-ven">reached a valuation of $4.5 billion</a>.
It also reflects a broader trend: seed rounds, especially in AI, are getting bigger. In 2015, the largest seed round was just $50 million. In 2025, PitchBook lists the largest closed seed at $200 million, <a href="https://fortune.com/2025/04/10/mira-murati-2-billion-seed-raise-ai-boom-economic-chaos/">noted</a> Fortune.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Murati launched Thinking Machines shortly after <a href="https://www.benzinga.com/news/24/09/41037848/openai-cto-mira-murati-steps-down-i-want-to-create-the-time-and-space-to-do-my-own-exploration-elon">departing OpenAI in late 2024</a>. Though details of the company's product or service remain vague, its website states its mission is "to make AI systems more widely understood, customizable, and generally capable."
Thinking Machines&#8217; <a href="https://in.benzinga.com/tech/25/02/43803027/mark-zuckerbergs-meta-and-sam-altmans-chatgpt-parent-bleed-talent-to-ex-open-ai-cto-mira-muratis-new-ai-venture">team includes OpenAI veterans</a> such as chief scientist John Schulman, who co-led the development of ChatGPT, and advisors Alec Radford and Bob McGrew. Schulman reportedly left Anthropic after a short tenure to reunite with Murati on the new venture.
Meanwhile, earlier this month, OpenAI also secured a historic $40 billion funding round, pushing its valuation to $300 billion. Major backers in the round include SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
According to data from PitchBook, this marks the <a href="https://www.benzinga.com/25/04/44580172/openai-finalizes-historic-40-billion-funding-round-valuing-company-at-300-billion-with-backing-from-softbank-and-microsoft">largest funding round ever recorded</a> and nearly doubles OpenAI's prior valuation of $157 billion.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://benzinga.com/25/03/44554189/openai-and-microsoft-back-mcp-standard-in-major-shift-toward-interoperable-ai-agents-that-can-think-click-and-navigate-the-web-but-google-ceo-sundar-pichai-appears-to-be-mulling-over-it-in-shakespearean-fashion-to-mcp-or-not-to-mcp" target="_blank" rel="noreferrer noopener">OpenAI And Microsoft Back MCP Standard For Web-Surfing AI Agents; Google&#8217;s Sundar Pichai Asks A Shakespearean Question</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

Media

MSFT

SFTBF

SFTBY

Former OpenAI CTO Mira Murati Targets Record-Breaking $2 Billion Seed Round For New AI Startup

The European Union and China have agreed to explore setting minimum prices for Chinese-made electric vehicles as an alternative to tariffs imposed last year, a European Commission spokesperson said Thursday.
What Happened: EU Trade Commissioner Maros Sefcovic spoke with Chinese Commerce Minister Wang Wentao within the past 24 hours, with negotiations set to begin immediately, reported Reuters.
The potential pricing agreement would replace EU tariffs currently ranging from 17.0% for BYD (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) to 35.3% for SAIC, on top of the standard 10% car import duty imposed last October.
&#8220;Any minimum prices would need to be as effective and enforceable as the EU tariffs,&#8221; Sefcovic has previously stated, noting that a single minimum price would likely be inadequate for complex products like cars.
See Also: <a href="https://www.benzinga.com/markets/25/04/44756353/xi-jinping-says-there-are-no-winners-in-tariff-war-as-china-slaps-125-tariffs-on-us-goods-urges-trump-to-immediately-correct-wrongdoings">Xi Jinping Says &#8216;There Are No Winners In Tariff War&#8217; As China Slaps 125% Tariffs On US Goods, Urges Trump To Immediately Correct &#8216;Wrongdoings&#8217;</a>
Why It Matters: The negotiations come amid escalating global trade tensions, with U.S. President Donald Trump recently announcing sweeping new tariffs.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk reportedly appealed directly to Trump to reverse these policies, advocating instead for a &#8220;free trade zone&#8221; between <a href="https://www.benzinga.com/news/25/04/44735140/most-people-dont-have-the-balls-to-do-it-says-mark-cuban-praising-musk-for-going-all-in-with-his-own-money-for-his-startups">Europe and the United States</a>. &#8220;At the end of the day, I hope it&#8217;s agreed that both Europe and the United States should move ideally to a zero-tariff situation,&#8221; Musk said during an Italian political event.
Despite Musk&#8217;s significant <a href="https://www.benzinga.com/markets/equities/25/04/44679026/elon-musk-made-unsucessful-appeals-to-trump-to-reverse-new-tariffs-as-tesla-likely-to-take-a-hit-report">political contributions to Republicans and his advisory role to Trump</a>, his intervention has been unsuccessful. Tesla&#8217;s stock has declined by more than 33.45% this year amid market uncertainty.
Meanwhile, the U.S. electric vehicle <a href="https://www.benzinga.com/25/04/44755934/us-q1-ev-sales-data-shows-106-yoy-growth-tesla-experiences-decline-but-still-dominates-domestic-ev-sales">market continues to grow</a>, with sales increasing 10.6% year-over-year in the first quarter of 2025. Tesla maintains market leadership with a 43.5% share despite an 8.6% sales decline, followed by General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) at 8.9% and Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) at 7.7%.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/25/04/44754594/gold-miners-rally-as-bullion-hits-3212-record-trump-tariffs-fuel-over-20-year-to-date-surge-across-sector">Gold Miners Rally As Bullion Hits $3,212: Trump Tariffs Fuel Over 20% Year-To-Date Surge Across Sector</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Global

Markets

BYDDY

TSLA

Europe, China Eye EV Price Pact To Avert Trump Tariff Escalation After Tesla CEO Elon Musk Pushes For Zero EU Tariffs Amid Declining Sales

The Trump administration announced a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44721874/trumps-tariff-pause-saves-market-from-edge-of-the-cliff-dan-ives-says-biggest-wild-card-still-remains">90-day halt on most tariffs</a>, sending global stocks on the rise after a period of uncertainty. However, U.S. President Donald Trump has refused to implement a halt on the 25% Tariffs on the automotive sector, much to the <a href="https://www.benzinga.com/25/04/44729157/michigan-auto-groups-criticize-trump-for-not-halting-auto-tariffs">criticism of stakeholders</a> in the automotive industry as well as policymakers.
What happened: In a new report published by Michigan-based Center for Automotive Research, the organization highlights how the Trump administration's 25% tariffs on the auto sector could cost the industry over $108 billion.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f6a8; New CAR Analysis Alert! &#x1f6a8; We&#39;ve just released an analysis on the impact of <a href="https://twitter.com/hashtag/tariffs?src=hash&amp;ref_src=twsrc%5Etfw">#tariffs</a> on imported <a href="https://twitter.com/hashtag/auto?src=hash&amp;ref_src=twsrc%5Etfw">#auto</a> parts &amp; light vehicles. The modern auto <a href="https://twitter.com/hashtag/SupplyChain?src=hash&amp;ref_src=twsrc%5Etfw">#SupplyChain</a> is complex, and these tariffs have significant implications. Download the full report here: <a href="https://t.co/1kaa2dKlFQ">https://t.co/1kaa2dKlFQ</a> <a href="https://t.co/Sj1kaN5IRn">pic.twitter.com/Sj1kaN5IRn</a>
&mdash; Center for Automotive Research (@cargroup) <a href="https://twitter.com/cargroup/status/1910392994101862792?ref_src=twsrc%5Etfw">April 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The report also shows that the administration's tariffs will cost the three Detroit-based auto manufacturers, namely General Motors Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), and Jeep and Chrysler parent company Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) nearly $42 billion.
Why it matters: The tariffs imposed on the Auto sector have forced companies to rethink their strategies. Stellantis scaled back on production in Canada and Mexico, which affected over 5 plants in the U.S., as the company also temporarily laid off 900 employees. Reports also suggest that General Motors has increased truck output at a plant in Indiana.
CAR says the study emphasizes the complexity of the modern automotive supply chain. Dr. K. Venkatesh Prasad, who is the Senior Vice President and Chief Innovation Officer at CAR, said, "automakers and their suppliers are often multinational companies with facilities spread out across the world, making it difficult to discern how much of a vehicle is domestically produced."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">DO NOT RETALIATE AND YOU WILL BE REWARDED
&mdash; The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1910058352278708638?ref_src=twsrc%5Etfw">April 9, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
This study comes in as the Trump administration shows no sign of backing down from its trade war with China, imposing a 125% tariff on Chinese goods. China responded with 84% tariffs on U.S. imports. The White House handle also shared a post on the social media platform X, warning countries to ‘not retaliate'.
Price action: STLA stock experienced a 30.28% year-to-date decline, currently trading at $8.91, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga's Future Of Mobility coverage by <a href="https://www.benzinga.com/topic/mobility">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44705972/ford-motor-general-motors-to-witness-higher-demand-as-american-automotives-reap-the-fruit-of-protectionism-says-expert-heres-a-list-of-potential-gainers-and-losers">Ford, GM To Witness &#8216;Higher Demand&#8217; As American Carmakers Set To &#8216;Reap The Fruit Of Protectionism,&#8217; Says Expert: Here&#8217;s A List Of Potential Gainers And Losers From Trump Tariffs</a></li>
</ul>
Photo courtesy: Shutterstock

FORD

STLA

Trump's 25% Tariffs Could Cost Auto Companies $108 Billion: Report

U.S. stock futures were volatile on Friday after losing steam on Thursday. Futures of major benchmark indices were lower in premarket.
Data from the Bureau of Labor Statistics on Thursday showed the<a href="https://www.benzinga.com/news/econ-s/25/04/44733390/march-inflation-rate-cools-far-more-than-expected-raises-hopes-for-near-term-fed-rate-cuts"> annual inflation rate falling</a> to a six-month low of 2.4% in March, down from 2.8% in February and below the expected 2.6%.
Monthly, the Consumer Price Index contracted by 0.1%, a decrease from the previous month&#8217;s 0.2% increase and below the anticipated 0.1% rise, marking the lowest monthly reading since May 2020.
Investors will keep an eye on the headline and core producer price index data for March and April&#8217;s consumer sentiment data, slated to be released later today. Major banks will kick off the earnings season as they report earnings before the market opens on Friday.
The 10-year Treasury bond yielded 4.40% and the two-year bond was at 3.80%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 61.6% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.49%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.34%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.33%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.32%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Friday. The SPY was down 0.52% to $521.85, while the QQQ declined 0.58% to $443.60, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Energy, information technology, and communication services sectors led Thursday&#8217;s U.S. stock market decline, overshadowing a rise in consumer staples.
The broader market saw the Dow Jones briefly plunge over 1,000 points as investors considered economic risks despite a newly announced 90-day tariff pause.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) was down 4%, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) declined 6%, and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) slipped 7% as these were the significant individual stock decliners.
On the economic front, the Consumer Price Index fell to 2.4% in March, below expectations, with monthly inflation turning negative for the first time since May 2020.
After Thursday&#8217;s fall, the Nasdaq 100 index was 17.46% lower than its previous high of 22,222.61 points. The S&amp;P 500 index was down 14.31% from its record of 6,147.43 points, and the Dow Jones declined 12.16% from its 52-week high of 45,073.63 points.
The Dow Jones index dropped 1,015 points or 2.50% to 39,593.66, whereas the S&amp;P 500 index declined 3.46% to 5,268.05. Nasdaq Composite tumbled to end 4.31% lower at 16,387.31, and the small-cap gauge, Russell 2000, slipped 4.27% to 1,831.39.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-4.31%</td>
<td>16,387.31</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-3.46%</td>
<td>5,268.05</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-2.50%</td>
<td>39,593.66</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-4.27%</td>
<td>1,831.39</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
As the U.S. Core consumer price inflation excluding food and energy moved down to 2.81%, the lowest level since March 2021. And the overall U.S. CPI moved down to 2.39% in March, the lowest level since February 2021.
&#8220;Fed is likely to cut rates again on June 18th,&#8221; said Charlie Bilello from Creative Planning in an X post.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Overall US CPI moved down to 2.39% in March, the lowest level since February 2021. US Core CPI (ex-Food/Energy) moved down to 2.81%, the lowest level since March 2021. Based on this data the Fed is likely to cut rates again on June 18th (25 bps cut down to 4.00-4.25%). <a href="https://t.co/2qI8nO4nDz">pic.twitter.com/2qI8nO4nDz</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1910313873929892200?ref_src=twsrc%5Etfw">April 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He added that this data &#8220;should be enough for the Fed to resume cutting rates in June.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">US Core CPI Inflation is back below 3% for the first time in 4 years. This should be enough for the Fed to resume cutting rats in June.<a href="https://t.co/l5IYmkeySJ">https://t.co/l5IYmkeySJ</a> <a href="https://t.co/pvOHrTLqaL">pic.twitter.com/pvOHrTLqaL</a>
&mdash; Charlie Bilello (@charliebilello) <a href="https://twitter.com/charliebilello/status/1910315991218659582?ref_src=twsrc%5Etfw">April 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
As tech stocks experienced significant volatility following President Donald Trump‘s tariff announcements, Alexander Morris, CEO of F/m Investments, viewed the pullback as a buying opportunity for select Magnificent 7 companies.
"We have long been investors in the Mag 7 — not all of them, but a handful of them — and you'll see us more into some Apple, which seems to be at a discount," Morris told Reuters. "We picked up some Meta, which seemed to have done well."
Morris recommends investors maintain a disciplined portfolio allocation, like a 60-40 mix, through market volatility, noting the repeated resurgence of such strategies.
He advises choosing an allocation and sticking with it through market cycles until life events necessitate a change, emphasizing its self-balancing nature. Morris also cautions against market timing, as significant returns often occur within a few key days throughout the year.
&#8220;The concern going forward is that prices will rise and the economy will slow,&#8221; said Cooper Howard, director, fixed income strategy at the Schwab Center for Financial Research. &#8220;This will put the Fed in a difficult place.&#8221;
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Friday:
<ul>
<li>The headline and core producer price index data for March will be released by 8:30 a.m. ET.</li>
</ul>
<ul>
<li>April&#8217;s preliminary consumer sentiment data will be announced, while St. Louis Fed President Alberto Musalem speaks at 10:00 a.m. ET.</li>
</ul>
<ul>
<li>New York Fed President John Williams will speak at 11:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) was up 0.019% in premarket on Friday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $2.20 per share on revenue of $16.57 billion.</li>
</ul>
<ul>
<li>Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) was 1.13% lower as Wall Street expects it to report earnings of $1.24 per share on revenue of $20.75 billion before the opening bell.</li>
</ul>
<ul>
<li>JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) rose 0.7% as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $4.61 per share on revenue of $44.11 billion.</li>
</ul>
<ul>
<li>Bank of New York Mellon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) dropped 1.16% as Wall Street expects it to report earnings of $1.51 per share on revenue of $4.77 billion before the opening bell.</li>
</ul>
<ul>
<li>BlackRock Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) was 0.14% higher as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $11.19 per share on revenue of $5.53 billion.</li>
</ul>
<ul>
<li>Fastenal Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) was 0.32% lower as Wall Street expects it to report earnings of 52 cents per share on revenue of $1.95 billion before the opening bell.</li>
</ul>
<ul>
<li>Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) declined 1.68% after reporting estimated consolidated shipments for the three months ending March 31 at 1.2 million units, representing a 9% year-on-year decline.</li>
</ul>
<ul>
<li>MSP Recovery Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) surged 171.88% after securing massive $1.2 billion debt relief via strategic partnerships and creation of an independent servicer.</li>
</ul>
<ul>
<li>Calamos Global Dynamic Income Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHW#NASDAQ">CHW</a>) jumped 43.10% after strategically choosing Pretoria&#8217;s LightDeepEarth as its preferred assay lab to boost assay result turnaround for its Heavy Mineral Sands program and improve operational efficiency.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 0.15% to hover around $60.22 per barrel.
Gold Spot US Dollar advanced 1.30% to hover around $3,216.91 per ounce. Its fresh record high stood at $3,227.23 per ounce. The U.S. Dollar Index spot was lower by 1.69% at the 99.163 level.
Asian markets were mixed on Friday as India's S&amp;P BSE Sensex, China&#8217;s CSI 300, and Hong Kong's Hang Seng index advanced. Whereas, Japan's Nikkei 225, Australia's ASX 200, and South Korea's Kospi index declined. European markets were mostly lower in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44728276/spy-qqq-call-volumes-spiked-minutes-before-tariff-pause-announcement-alexandria-ocasio-cortez-demands-disclosure-from-congress-members">SPY, QQQ Call Volumes Spiked Minutes Before Tariff Pause Announcement: Alexandria Ocasio-Cortez Demands Disclosure From Congress Members</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Bonds

Guidance

Futures

Commodities

Treasuries

Economics

Federal Reserve

Pre-Market Outlook

Analyst Ratings

ETFs

AAPL

FAST

MSPR

NVDA

US Stocks Likely To Open Lower As Volatility Persists Before Bank Earnings: 'Fed Is Likely To Cut Rates Again On June 18th,' Says Expert

<a href="https://www.wsj.com/livecoverage/stock-market-trump-tariffs-trade-war-04-11-25?mod=WSJ_home_mediumtopper_pos_1" title="https://www.wsj.com/livecoverage/stock-market-trump-tariffs-trade-war-04-11-25?mod=WSJ_home_mediumtopper_pos_1">https://www.wsj.com/livecoverage/stock-market-trump-tariffs-trade-war-04-11-25?mod=WSJ_home_mediumtopper_pos_1</a>

Macro Economic Events

China's Finance Ministry Earlier Announced It Will Raise Additional Tariffs On U.S. Goods To 125% From 84%

<a href="https://www.reuters.com/business/autos-transportation/tesla-suspends-taking-new-orders-model-s-model-x-chinese-website-2025-04-11/" title="https://www.reuters.com/business/autos-transportation/tesla-suspends-taking-new-orders-model-s-model-x-chinese-website-2025-04-11/">https://www.reuters.com/business/autos-transportation/tesla-suspends-taking-new-orders-model-s-model-x-chinese-website-2025-04-11/</a>

Reuters Reported Earlier, Tesla Stopped Taking New Orders For Model S And Model X On It's Chinese Website

Shares of argenx SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) rose sharply in today's pre-market trading after the company announced the FDA approval of VYVGART Hytrulo prefilled syringe for self-injection in generalized myasthenia gravis and <a href="https://www.benzinga.com/quote/ARGX">chronic inflammatory demyelinating polyneuropathy.</a>
argenx shares jumped 5.1% to $573.88 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>MSP Recovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSPR#NASDAQ">MSPR</a>) rose 167% to $3.43 in pre-market trading as the company announced strategic term sheet providing prospective liquidity and restructuring of existing agreements to remove corporate guaranteed debt by over $1.2 billion as well as new agreements aimed at driving future growth.</li>
<li>Sharps Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) surged 73.6% to $0.0318 in pre-market trading after jumping 30% on Thursday.</li>
<li>Enzo Biochem, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENZ#NYSE">ENZ</a>) gained 26.5% to $0.3300 in pre-market after dipping 22% on Thursday.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) rose 26.4% to $0.8198 in pre-market trading. Actelis Networks recently announced it received a new order to modernize Orange County&#8217;s traffic infrastructure.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) rose 25.6% to $5.10 in pre-market trading. Venus Concept announced closing of $1.1 million registered direct offering of common stock priced at-the-market under Nasdaq rules.</li>
<li>DMC Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) gained 21.7% to $7.90 in pre-market trading.</li>
<li>Recursion Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) jumped 19.1% to $5.37 in pre-market trading.</li>
<li>Certara, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) surged 18.1% to $12.41 in pre-market trading after gaining 8% on Thursday.</li>
<li>Simulations Plus, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) gained 13.7% to $29.23 in pre-market trading. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>AlTi Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) fell 57.3% to $1.20 in pre-market trading after declining around 6% on Thursday.</li>
<li>cbdMD, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NYSE">YCBD</a>) shares tumbled 38.9% to $0.1701 in pre-market trading. CbdMD announced shareholder approval of automatic conversion of series a preferred stock and other results from annual meeting.</li>
<li>Nexa Resources S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) fell 32% to $4.01 in today's pre-market trading.</li>
<li>Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares fell 27.1% to $1.59 in pre-market trading.</li>
<li>Palatin Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PTN#NYSE">PTN</a>) fell 16.8% to $0.3510 in pre-market trading after the company announced it received a NYSE American notice of delisting.</li>
<li>Betterware de México, S.A.P.I. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWMX#NYSE">BWMX</a>) shares fell 24% to $8.21 in pre-market trading. Betterware de México will report its first quarter results after the U.S. market close on Thursday, April 24.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) shares dipped 22.3% to $2.20 in pre-market trading.</li>
<li>InnovAge Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INNV#NASDAQ">INNV</a>) fell 14.9% to $2.35 in pre-market trading.</li>
<li>Costamare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>) dipped 14.3% to $7.42 in pre-market trading after falling 5% on Thursday.</li>
<li>Maze Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) declined 12.8% to $6.62 in pre-market trading after falling 5% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44734419/top-2-real-estate-stocks-that-may-keep-you-up-at-night-this-month">Top 2 Real Estate Stocks That May Keep You Up At Night This Month</a> </li>
</ul>
Photo via Shutterstock

Trading Ideas

ALTI

ARGX

ASNS

BOOM

BWMX

CERT

CMRE

INNV

MAZE

NEXA

ONVO

RXRX

SLSR

STSS

VERO

YCBD

Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket

China announced on Thursday it would immediately restrict Hollywood film imports in retaliation for President Donald Trump&#8216;s tariff increases on Chinese goods, targeting a high-profile American export as trade tensions intensify.
What Happened: A spokesperson for the National Film Administration said, &#8220;The wrong move by the U.S. government to abuse tariffs on China will inevitably further reduce the domestic audience&#8217;s favorability towards American films. We will follow market rules, respect the audience&#8217;s choice, and moderately reduce the number of American films imported.&#8221;&nbsp;
The move could significantly impact major U.S. studios and entertainment companies with Chinese market exposure.
IMAX Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMAX#NYSE">IMAX</a>) faces particular <a href="https://in.benzinga.com/25/04/44708103/why-investors-should-watch-chinas-service-trade-amid-us-tariff-escalation-disney-and-imax-most-impacted">exposure with 23% of its revenue derived from China</a>, where 45% of all IMAX screens are located. Despite this, the company recently reported strong performance in China during 2025&#8217;s first quarter, driven primarily by the domestic blockbuster &#8220;Ne Zha 2.&#8221;
&#8220;IMAX is benefiting from a blockbuster-heavy 2025-2026 slate and tighter cost control, especially in China,&#8221; noted Rosenblatt Securities analyst Steve Frankel, who maintains a &#8220;Buy&#8221; rating on the stock.
See Also: US Stock Futures Fall, Nikkei Crashes Over 5% As Markets Reel From Trump&#8217;s Tariff Shock
Why It Matters: Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and Warner Bros Discovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) also face potential impacts. Disney&#8217;s Marvel superhero movie &#8220;Thunderbolts&#8221; secured permission to debut in China on Apr. 30, but the fate of other summer blockbusters remains uncertain. WBD&#8217;s stock has already fallen 21.80% over the last month amid these concerns.
The restrictions follow Beijing&#8217;s broader retaliation against Washington&#8217;s tariff hikes, which includes increasing its <a href="https://www.benzinga.com/25/04/44708618/china-retaliates-with-massive-84-tariff-hike-on-us-goods-amid-escalating-trade-war">levies on U.S. goods from 34% to 84%</a> and filing a World Trade Organization complaint.
Two influential Chinese bloggers with Communist Party connections recently suggested China would &#8220;reduce or ban the import of U.S.-made films&#8221; along with restricting American companies from <a href="https://www.benzinga.com/25/04/44708103/why-investors-should-watch-chinas-service-trade-amid-us-tariff-escalation-disney-and-imax-most-impacted">government procurement processes</a>.
For U.S. studios, the $600 million earned in China last year represents a small but <a href="https://www.benzinga.com/news/25/04/44717030/whats-going-on-with-warner-bros-discovery-wbd-stock">strategic portion of their global revenue</a>. However, China&#8217;s growing preference for domestic content had already created challenges for Hollywood before these new restrictions.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/25/04/44752456/obama-era-economist-jason-furman-says-trump-tariffs-now-higher-more-inflationary-than-announced-rais" target="_blank" rel="noreferrer noopener">Obama-Era Economist Jason Furman Says Trump Tariffs ‘Now Higher &amp; More Inflationary' Than Announced: Raising China Levies Outweighs 90-Day Delay On Others</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

IMAX

Hollywood Becomes Collateral Damage In Trump Tariff War As China Slashes Film Imports, Says US Actions Will Inevitably Reduce 'Favorability' Towards American Films

China has significantly increased tariffs on U.S. goods from 84% to an unprecedented 125% on Friday. This move comes as a countermeasure to the Trump administration&#8217;s similar actions.
What Happened: China&#8217;s&nbsp;Customs Tariff Commission of the&nbsp;State Council has declared that any additional tariffs imposed by the U.S. will be disregarded. "Given that U.S. exports to China already have no market acceptability under the current tariff rates, if the U.S. further imposes additional tariffs on Chinese goods, China will simply ignore them,"
The commission maintains that U.S. exports to China are already struggling to find market acceptability under the current tariff rates, <a href="https://www.scmp.com/economy/china-economy/article/3306151/china-raises-tariffs-us-goods-125?module=breaking&amp;pgtype=homepage">reported</a> the South China Morning Post.
A spokesperson for the Ministry of Commerce emphasized China&#8217;s commitment to safeguarding its legitimate rights and interests, supporting the multilateral trading system, and maintaining the stability of the international economic order. 
The ministry criticized the U.S. tariff measures as &#8220;a typical act of unilateral&nbsp;bullying and coercion,&#8221; which violate&nbsp;World Trade Organization rules and&nbsp;undermine the rules-based&nbsp;multilateral trading system and international&nbsp;economic order.
The spokesperson also called on the U.S. to &#8220;immediately correct its wrongdoings and&nbsp;revoke all unilateral tariffs imposed&nbsp;on China.&#8221;
In his first reaction to President Donald Trump&#8216;s tariffs on China, Xi Jinping told visiting Spanish Prime Minister Pedro Sanchez, "There are no winners in the tariff war and standing against the world ultimately results in self-isolation," as per state news agency Xinhua.
No matter how the external environment shifts, China will maintain its resolve and focus, dedicating itself to managing its own affairs efficiently,&#8221; added Xi.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44749653/bitcoin-ethereum-xrp-dogecoin-lose-steam-trader-warns-of-new-lows-under-one-condition" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Lose Steam, Trader Warns Of &#8216;New Lows&#8217; Under One Condition &#8211; Benzinga</a>
Why It Matters: The decision to increase tariffs comes as President Donald Trump awaits negotiation talks with his &#8216;friend&#8217; Xi Jinping. 
According to China expert and political commentator Gordon Chang, the Chinese President&nbsp;is avoiding direct negotiations with President Trump to prevent <a href="https://www.benzinga.com/markets/25/04/44755977/xi-jinping-steering-clear-of-trump-negotiations-to-avoid-political-backlash-at-home-says-expert-china-doesnt-have-any-cards-in-this-game">potential political backlash</a> at home. Xi is in a difficult position where initiating a conversation with Trump about the trade war could lead to backlash from his fellow Communist Party leaders. 
Notably, China is not immune to the adverse impact from Trump&#8217;s tariffs. Goldman Sachs downgraded China&#8217;s growth forecast and warned of risk to 20 million export-linked jobs in the nation. However, the investment bank cited overall global economic gloom as a reason besides Trump&#8217;s tariffs. 
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/25/04/44728777/pence-calls-trumps-tariff-moves-misstep-cites-potential-economic-harm-to-working-families" target="_blank" rel="noreferrer noopener">Former Vice President Mike Pence Calls Trump&#8217;s Tariff Moves &#8216;Misstep,&#8217; Cites Potential Economic Harm To Working Families</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Xi Jinping Says 'There Are No Winners In Tariff War' As China Slaps 125% Tariffs On US Goods, Urges Trump To Immediately Correct 'Wrongdoings'

Gen Z workers are facing a sharp decline in confidence, driven by recession worries, stagnant pay, and an increasingly competitive job market, a new report finds.
What Happened: The youngest generation of workers is feeling mounting pressure from a tough economic climate, as reported by <a href="https://fortune.com/2025/04/10/gen-z-workers-confidence-record-low-recession-fears-tough-job-market-layoffs/">Fortune</a>. This is primarily attributed to mass <a href="https://www.benzinga.com/news/25/03/44277188/a-poverty-sentence-heres-why-some-say-losing-a-federal-job-is-worse-than-being-fired-in-the-private-sector">federal workforce layoffs</a> and a complex job market.
Data from&nbsp;Glassdoor&nbsp;reveals that less than half of all workers are optimistic about the future. This figure has hit&nbsp;a record low for entry-level&nbsp;employees, with only 43.4% feeling positive about their employer&#8217;s 6-month business outlook, the lowest since Glassdoor started collecting data in 2016.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44749653/bitcoin-ethereum-xrp-dogecoin-lose-steam-trader-warns-of-new-lows-under-one-condition" target="_blank" rel="noreferrer noopener">Mark Cuban Advises GenZ To &#8216;Spend Every Waking Minute Learning About AI:&#8217; Here&#8217;s A List Of AI Investment Opportunities For Long Term</a>
&#8220;Entry&nbsp;level workers have less job&nbsp;security. And so as they&nbsp;see these economic headwinds on&nbsp;the horizon, there's an understandable&nbsp;concern that they might be&nbsp;the first ones to lose&nbsp;their jobs in a recession,&nbsp;or they'll be left out&nbsp;in the cold when trying&nbsp;to find a new job,&#8221; said Daniel Zhao, Glassdoor's lead economist.
Recent data from&nbsp;LinkedIn&nbsp;also indicates that U.S. workers feel&nbsp;worse about the future than&nbsp;they did during the peak&nbsp;of the pandemic in April&nbsp;2020. The&nbsp;slowing jobs market and the&nbsp;<a href="https://www.benzinga.com/personal-finance/25/01/43303778/bill-gates-says-this-book-on-ai-will-change-every-industry-predicts-millions-of-jobs-will-vanish-by-2030">impact of AI </a>are major contributors to worker anxiety.
Stock market volatility this week, triggered by President Trump&#8217;s &#8220;reciprocal tariffs&#8221;, has further eroded workers&#8217; confidence. Despite a <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/04/44749586/trump-averts-financial-crisis-with-tariff-pause-but-not-a-recession-josh-brown">90-day pause</a> on these tariffs, with the exception of China, economists warn that significant damage has been done.
Why It Matters: Gen Z's confidence slump reflects growing fears about job security in a volatile economy. <a href="https://www.benzinga.com/news/25/03/44277188/a-poverty-sentence-heres-why-some-say-losing-a-federal-job-is-worse-than-being-fired-in-the-private-sector">Federal layoffs</a>, <a href="https://www.benzinga.com/markets/equities/25/02/43761822/jamie-dimon-says-ai-will-change-your-jobs-but-it-may-eliminate-some-careers-as-well-reskill-and-redeploy-people">AI-driven job cuts</a>, and a <a href="https://www.benzinga.com/government/regulations/25/04/44629640/us-services-sector-slows-sharply-as-hiring-drops-tariff-pressures-mount">cooling services sector</a> are leaving young workers uncertain about their future. Entry-level optimism has hit a record low, highlighting the pressure this generation faces.
Meanwhile, billionaire investor Mark Cuban is <a href="https://www.benzinga.com/markets/25/03/44354638/mark-cuban-advises-genz-to-spend-every-waking-minute-learning-about-ai-heres-a-list-of-ai-investment-opportunities-for-long-term">encouraging Gen Z to future-proof</a> their careers by gaining skills in artificial intelligence. As AI continues to reshape industries, investors looking to tap into this transformation may want to explore key opportunities in the AI space to strengthen their portfolios.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:&nbsp;<a href="https://benzinga.com/markets/equities/25/04/44728524/adam-schiff-and-elizabeth-warren-call-for-investigation-into-possible-insider-trading-by-trump-a" target="_blank" rel="noreferrer noopener">Steve Jobs Detested Decision Fatigue, Now Gen Z Is Copying His Style Playbook To Stay Sane, Stay Employed And Stay Out Of Trouble</a>

Gen Z Workers Hit Confidence Low Amid Layoffs, Stagnant Pay And Fierce Job Market

Even as President Donald Trump paused the reciprocal tariffs for 90 days on Wednesday, he later confirmed in a conversation with reporters at his Oval Office that pharmaceutical companies would face tariffs.
What Happened: The rally in pharma stocks was short-lived after the stocks reversed course on Thursday. When a reporter asked President Trump if he would go ahead and levy tariff duties on pharmaceutical stocks, he said, &#8220;Yeah, well, I will be because we want them coming back.&#8221;
&#8220;You know, we realized during COVID-19 that we don&#8217;t make our drugs and our pharmaceuticals in this country. So, I realized that, and it was a big realization,&#8221; he added.
Citing the emergency during COVID-19, he stated that he wanted the pharma companies to produce drugs in the U.S.
&#8220;We had to go to China to get drugs, we had to go to other places, we don&#8217;t make it. That&#8217;s because we let them leave, and now if they want to come back, we&#8217;re going to put tariffs on the pharmaceutical companies, and they&#8217;re going to all want to come back,&#8221; Trump said.
The pharma stocks tumbled on Thursday after Trump&#8217;s confirmation of tariffs.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Pharma Stocks</td>
<td>Thursday&#8217;s Performance</td>
<td>YTD Performance</td>
<td>One Year Performance</td>
</tr>
<tr>
<td>Eli Lilly And Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>-4.35%</td>
<td>-7.35%</td>
<td>-5.09%</td>
</tr>
<tr>
<td>AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</td>
<td>-3.14%</td>
<td>-2.92%</td>
<td>3.99%</td>
</tr>
<tr>
<td>Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</td>
<td>-6.10%</td>
<td>-11.15%</td>
<td>2.73%</td>
</tr>
<tr>
<td>Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)</td>
<td>-5.26%</td>
<td>-23.60%</td>
<td>-40.63%</td>
</tr>
<tr>
<td>Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</td>
<td>-3.87%</td>
<td>-18.87%</td>
<td>-18.03%</td>
</tr>
<tr>
<td>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</td>
<td>-3.66%</td>
<td>10.36%</td>
<td>47.71%</td>
</tr>
<tr>
<td>Merck &amp; Co Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td>-5.32%</td>
<td>-21.80%</td>
<td>-38.53%</td>
</tr>
<tr>
<td>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>)</td>
<td>-3.33%</td>
<td>8.54%</td>
<td>4.23%</td>
</tr>
<tr>
<td>Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</td>
<td>-1.51%</td>
<td>3.24%</td>
<td>-0.07%</td>
</tr>
</tbody>
</table>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/04/44755181/pentagon-slashes-5-1-billion-in-accenture-deloitte-booz-allen-contracts-thats-a-lot-of-consulting">Pentagon Slashes $5.1 Billion In Accenture, Deloitte, Booz Allen Contracts: &#8216;That&#8217;s A Lot Of Consulting&#8217;</a>
Why It Matters: Despite a 90-day pause on reciprocal tariffs, base global tariffs of 10% and China tariffs of 125%, along with sector-specific tariffs of 25% on steel and aluminum, auto, and auto parts remain in place. Adding to it, the President hinted that he could soon announce tariffs on pharmaceutical companies.
Here are some of the pharmaceutical industry-linked exchange-traded funds that could be impacted.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Pharma ETFs</td>
<td>YTD Performance</td>
<td>One Year Performance</td>
</tr>
<tr>
<td>VanEck Pharmaceutical ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPH#NASDAQ">PPH</a>)</td>
<td>-7.02%</td>
<td>-7.51%</td>
</tr>
<tr>
<td>iShares US Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHE#NYSE">IHE</a>)</td>
<td>-7.04%</td>
<td>-6.08%</td>
</tr>
<tr>
<td>Invesco Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJP#NYSE">PJP</a>)</td>
<td>-10.13%</td>
<td>-4.37%</td>
</tr>
<tr>
<td>SPDR S&amp;P Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPH#NYSE">XPH</a>)</td>
<td>-14.05%</td>
<td>-11.45%</td>
</tr>
<tr>
<td>KraneShares MSCI All China Health Care Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KURE#NYSE">KURE</a>)</td>
<td>2.88%</td>
<td>0.35%</td>
</tr>
<tr>
<td>First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXH#NASDAQ">FTXH</a>)</td>
<td>-11.54%</td>
<td>-10.18%</td>
</tr>
<tr>
<td>Direxion Daily Pharmaceutical &amp; Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PILL#NYSE">PILL</a>)</td>
<td>-41.35%</td>
<td>-43.86%</td>
</tr>
</tbody>
</table>
</figure>
Price Action: After Thursday&#8217;s fall, following Wednesday&#8217;s rebound, the Nasdaq 100 index was 17.46% lower than its previous high of 22,222.61 points. The S&amp;P 500 index was down 14.31% from its record of 6,147.43 points, and the Dow Jones declined 12.16% from its 52-week high of 45,073.63 points.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, ended lower on Thursday. The SPY was down 4.38% to $524.58, while the QQQ declined 4.25% to $446.18, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44728276/spy-qqq-call-volumes-spiked-minutes-before-tariff-pause-announcement-alexandria-ocasio-cortez-demands-disclosure-from-congress-members" target="_blank" rel="noreferrer noopener">SPY, QQQ Call Volumes Spiked Minutes Before Tariff Pause Announcement: Alexandria Ocasio-Cortez Demands Disclosure From Congress Members</a></li>
</ul>
Photo courtesy: Shutterstock

ABBV

AMGN

FTXH

GILD

iShares Dow Jones US Pharmaceuticals Index Fund

KURE

PILL

Merrill Lynch Pharmaceutical HOLDRs Trust

REGN

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies

Press Releases

Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors - Contact Levi & Korsinsky

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA

NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit

Legal

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action – NTLA

The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NTLA

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Lawsuit – NTLA

Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA

Comments

Intellia Therapeutics

Interés en corto

Intellia Therapeutics (NASDAQ:NTLA) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL